| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.
|
Ophthalmology
|
2012
|
4.70
|
|
2
|
A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.
|
Nat Genet
|
2006
|
3.96
|
|
3
|
Clinical classification of age-related macular degeneration.
|
Ophthalmology
|
2013
|
2.92
|
|
4
|
The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis.
|
Am J Epidemiol
|
2012
|
2.87
|
|
5
|
Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).
|
Arch Ophthalmol
|
2006
|
2.82
|
|
6
|
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis.
|
Ophthalmology
|
2007
|
2.46
|
|
7
|
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.
|
Hum Mol Genet
|
2011
|
1.98
|
|
8
|
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.
|
Cochrane Database Syst Rev
|
2014
|
1.95
|
|
9
|
Age related macular degeneration.
|
BMJ
|
2003
|
1.72
|
|
10
|
New treatments for neovascular acute macular degeneration.
|
BMJ
|
2007
|
1.69
|
|
11
|
Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion.
|
Arch Ophthalmol
|
2002
|
1.67
|
|
12
|
Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis.
|
Am J Epidemiol
|
2011
|
1.42
|
|
13
|
Bevacizumab for the treatment of neovascular age related macular degeneration.
|
BMJ
|
2010
|
1.40
|
|
14
|
Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration.
|
Am J Clin Nutr
|
2008
|
1.29
|
|
15
|
Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking.
|
PLoS Med
|
2007
|
1.27
|
|
16
|
Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization.
|
Ophthalmology
|
2007
|
1.26
|
|
17
|
Sunlight exposure, antioxidants, and age-related macular degeneration.
|
Arch Ophthalmol
|
2008
|
1.21
|
|
18
|
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people.
|
Am J Epidemiol
|
2011
|
1.19
|
|
19
|
Prevalence of cataract in an older population in India: the India study of age-related eye disease.
|
Ophthalmology
|
2011
|
1.19
|
|
20
|
Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies.
|
Hum Mutat
|
2011
|
1.17
|
|
21
|
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.
|
Ophthalmology
|
2012
|
1.16
|
|
22
|
Visual impairment and quality of life in the older European population, the EUREYE study.
|
Acta Ophthalmol
|
2009
|
1.14
|
|
23
|
Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype.
|
Int J Epidemiol
|
2012
|
1.12
|
|
24
|
Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study.
|
Ophthalmology
|
2013
|
1.11
|
|
25
|
Evidence for association of endothelial nitric oxide synthase gene in subjects with glaucoma and a history of migraine.
|
Invest Ophthalmol Vis Sci
|
2005
|
1.10
|
|
26
|
Psychophysical function in age-related maculopathy.
|
Surv Ophthalmol
|
2009
|
1.09
|
|
27
|
EPHA2 polymorphisms and age-related cataract in India.
|
PLoS One
|
2012
|
1.06
|
|
28
|
Prevalence of early and late age-related macular degeneration in India: the INDEYE study.
|
Invest Ophthalmol Vis Sci
|
2009
|
1.05
|
|
29
|
Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study.
|
Ophthalmic Epidemiol
|
2004
|
1.05
|
|
30
|
Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration.
|
Invest Ophthalmol Vis Sci
|
2008
|
1.04
|
|
31
|
Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population.
|
Invest Ophthalmol Vis Sci
|
2008
|
1.03
|
|
32
|
Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study.
|
Invest Ophthalmol Vis Sci
|
2007
|
1.03
|
|
33
|
AMD and micronutrient antioxidants.
|
Curr Eye Res
|
2004
|
1.02
|
|
34
|
Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.
|
Ophthalmology
|
2012
|
1.00
|
|
35
|
Fundus autofluorescence in age-related macular degeneration: an epiphenomenon?
|
Invest Ophthalmol Vis Sci
|
2006
|
0.97
|
|
36
|
DNA-based eye colour prediction across Europe with the IrisPlex system.
|
Forensic Sci Int Genet
|
2011
|
0.94
|
|
37
|
Prevalence of lens opacities in North India: the INDEYE feasibility study.
|
Invest Ophthalmol Vis Sci
|
2007
|
0.93
|
|
38
|
Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film?
|
Ophthalmology
|
2003
|
0.93
|
|
39
|
Associations between aspirin use and aging macula disorder: the European Eye Study.
|
Ophthalmology
|
2011
|
0.93
|
|
40
|
Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis.
|
Ophthalmology
|
2009
|
0.93
|
|
41
|
Increasing use of a new health technology during the wait for NICE guidance: findings from the third national tracker survey of photodynamic therapy.
|
J Public Health (Oxf)
|
2004
|
0.92
|
|
42
|
Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy.
|
Retina
|
2009
|
0.92
|
|
43
|
Prevalence and risk factors for vitamin C deficiency in north and south India: a two centre population based study in people aged 60 years and over.
|
PLoS One
|
2011
|
0.91
|
|
44
|
Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study.
|
Ophthalmology
|
2013
|
0.91
|
|
45
|
Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype.
|
Invest Ophthalmol Vis Sci
|
2005
|
0.88
|
|
46
|
Inverse association of vitamin C with cataract in older people in India.
|
Ophthalmology
|
2011
|
0.88
|
|
47
|
Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort.
|
Mol Vis
|
2010
|
0.87
|
|
48
|
Small RNAs from plants, bacteria and fungi within the order Hypocreales are ubiquitous in human plasma.
|
BMC Genomics
|
2014
|
0.86
|
|
49
|
Economic cost of age-related macular degeneration: a review of recent research.
|
Drugs Aging
|
2006
|
0.86
|
|
50
|
An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism.
|
Invest Ophthalmol Vis Sci
|
2009
|
0.85
|
|
51
|
Formal and informal care utilisation amongst elderly persons with visual impairment.
|
Br J Ophthalmol
|
2007
|
0.84
|
|
52
|
A case-control study of drug risk factors for age-related macular degeneration.
|
Ophthalmology
|
2007
|
0.83
|
|
53
|
Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter.
|
Retina
|
2011
|
0.83
|
|
54
|
Antioxidants and diabetic retinopathy.
|
Curr Diab Rep
|
2013
|
0.82
|
|
55
|
VEGF and age-related macular degeneration.
|
Ophthalmology
|
2009
|
0.82
|
|
56
|
Age-related macular degeneration: current treatment and future options.
|
Ther Adv Chronic Dis
|
2011
|
0.82
|
|
57
|
Carotenoids and co-antioxidants in age-related maculopathy: design and methods.
|
Ophthalmic Epidemiol
|
2008
|
0.82
|
|
58
|
Macular pigment and age-related macular degeneration: longitudinal data and better techniques of measurement are needed.
|
Invest Ophthalmol Vis Sci
|
2008
|
0.82
|
|
59
|
Age related macular degeneration.
|
BMJ
|
2006
|
0.81
|
|
60
|
Verteporfin photodynamic therapy cohort study: report 2: clinical measures of vision and health-related quality of life.
|
Ophthalmology
|
2009
|
0.81
|
|
61
|
Complement inhibitors for age-related macular degeneration.
|
Cochrane Database Syst Rev
|
2014
|
0.80
|
|
62
|
Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomes.
|
Ophthalmology
|
2009
|
0.80
|
|
63
|
A Candidate Gene Association Study Identifies DAPL1 as a Female-Specific Susceptibility Locus for Age-Related Macular Degeneration (AMD).
|
Neuromolecular Med
|
2015
|
0.80
|
|
64
|
VEGF-targeted therapy and beyond: pharmacotherapy and emerging treatments in agerelated macular degeneration.
|
Expert Rev Clin Pharmacol
|
2010
|
0.80
|
|
65
|
Morphometric analysis of angiograms of exudative lesions in age-related macular degeneration.
|
Arch Ophthalmol
|
2004
|
0.79
|
|
66
|
Early features of AMD.
|
Ophthalmology
|
2007
|
0.79
|
|
67
|
Visual outcome after antioxidant supplementation.
|
Ophthalmology
|
2013
|
0.79
|
|
68
|
A posteriori-derived dietary patterns and retinal vessel caliber in an elderly population.
|
Invest Ophthalmol Vis Sci
|
2013
|
0.78
|
|
69
|
Polymorphisms in ARMS2/HTRA1 and complement genes and age-related macular degeneration in India: findings from the INDEYE study.
|
Invest Ophthalmol Vis Sci
|
2012
|
0.78
|
|
70
|
Retinal pigment epithelial cell DNA is damaged by exposure to benzo[a]pyrene, a constituent of cigarette smoke.
|
Exp Eye Res
|
2002
|
0.78
|
|
71
|
Severity staging by early features of age-related maculopathy exhibits weak relationships with functional deficits on SWS grating acuity.
|
Invest Ophthalmol Vis Sci
|
2006
|
0.78
|
|
72
|
Grading of age-related maculopathy: slit-lamp biomicroscopy versus an accredited grading center.
|
Retina
|
2009
|
0.78
|
|
73
|
Systemic safety of anti-VEGF drugs: a commentary.
|
Expert Opin Drug Saf
|
2014
|
0.77
|
|
74
|
The effect of lutein- and zeaxanthin-rich foods v. supplements on macular pigment level and serological markers of endothelial activation, inflammation and oxidation: pilot studies in healthy volunteers.
|
Br J Nutr
|
2012
|
0.77
|
|
75
|
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Outcomes in Eyes With Poor Initial Vision.
|
Retina
|
2015
|
0.77
|
|
76
|
Treating early choroidal neovascularisation with pegaptanib sodium in patients with neovascular age-related macular degeneration: findings of the PERSPECTIVES study.
|
Br J Ophthalmol
|
2012
|
0.77
|
|
77
|
Rasch analysis of the daily living tasks dependent on vision (DLTV).
|
Invest Ophthalmol Vis Sci
|
2007
|
0.76
|
|
78
|
How does the short-wavelength-sensitive contrast sensitivity function for detection and resolution change with age in the periphery?
|
Vision Res
|
2008
|
0.76
|
|
79
|
Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).
|
Ophthalmologica
|
2017
|
0.76
|
|
80
|
Use of Cooking Fuels and Cataract in a Population-Based Study: The India Eye Disease Study.
|
Environ Health Perspect
|
2016
|
0.75
|
|
81
|
CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
|
Retina
|
2016
|
0.75
|
|
82
|
Trends in provision of photodynamic therapy and clinician attitudes: a tracker survey of a new health technology.
|
BMC Health Serv Res
|
2005
|
0.75
|
|
83
|
Genotype-phenotype associations in neovascular age-related macular degeneration.
|
Retina
|
2012
|
0.75
|
|
84
|
Stereotactic radiotherapy for polypoidal choroidal vasculopathy: a pilot study.
|
Ophthalmologica
|
2014
|
0.75
|
|
85
|
Five authors reply.
|
Am J Epidemiol
|
2013
|
0.75
|
|
86
|
Diagnostic and Therapeutic Challenges.
|
Retina
|
2017
|
0.75
|
|
87
|
Evidence underlying the clinical management of diabetic macular oedema.
|
Clin Med
|
2013
|
0.75
|
|
88
|
IDENTIFYING FEATURES OF EARLY AND LATE AGE-RELATED MACULAR DEGENERATION: A Comparison of Multicolor Versus Traditional Color Fundus Photography.
|
Retina
|
2017
|
0.75
|
|
89
|
The effects of high ambient glucose on the radiosensitivity of retinal microvascular endothelial cells and pericytes.
|
Curr Eye Res
|
2002
|
0.75
|